Blog Band - Page 251 of 266

Digital Healthcare in India – Current Trends & Future

Digital healthcare means using communications and information technologies in medicine to diagnose, predict, treat, and monitor diseases. It is also widely used for prognosis, rehabilitation, behavioral health, and public health. Indians have witnessed a surge of smartphone and internet use since the last decade. This had led to an easier delivery of smart digital solutions.…

BySenior EditorOctober 5, 20200Comments

INSIGHTS+

Insights+ Key Biosimilars Events of September 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients. Hence, the providers are more likely to adopt biosimilars as a 'reference…

BySenior EditorOctober 1, 20200Comments

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease PharmaShots is keeping a track of all of the important updates in the Life-sciences…

BySenior EditorSeptember 30, 20200Comments

THOUGHTSPOT

COVID-19 – Where Does The Pharmaceutical Industry Go From Here?

With the race to develop an effective vaccine becoming intense, how has the coronavirus pandemic changed the pharmaceutical industry, and what can we expect in the long- and short-term? Let's see. The year 2020, and the new decade as a whole, has definitely got off to the worst possible start and we have a pandemic…

BySenior EditorSeptember 28, 20200Comments

TOP 20

Top 20 Oncology Companies by Total Products of 2019

To remain successful in the oncology market- change is now a key to adapt to this altering market dynamics. A recent development in science and technology platforms are likely to grow faster for cancer treatment in comparison to other therapy areas. However- despite robust levels of pipeline activity- oncology remains a challenging area for research…

ByPrince GiriSeptember 24, 20200Comments

VIEWPOINTS

PharmaShots Interview: Genentech’s Dr. Neil Collinson Shares Insights on Xofluza

In a recent interview with PharmaShots, Dr. Neil Collinson, the Senior Principal Clinical Development Scientist at Genentech / Roche shares his insights and highlights on Xofluza. Shots: The P-III BLOCKSTONE study demonstrated that the proportion of household members who became symptomatically ill following infection with influenza was significantly lower in those treated preventively with Xofluza…

BySenior EditorSeptember 22, 20200Comments

INSIGHTS+

Insights+: The US FDA New Drug Approvals in August 2020

The US FDA has approved multiple NDAs and BLAs in Aug 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 69 novel products so far in 2020, including 10 in Aug 2020. Additionally,…

BySenior EditorSeptember 17, 20200Comments

THOUGHTSPOT

COVID-19 Treatment in India and Abroad

In late 2019, a mysterious virus causing infection consisting of dry cough, fever tiredness, and last pneumonia first appeared in Wuhan, China. The world health organization (WHO) named the disease as Coronavirus 2019 (Covid-19). Interestingly, Covid-19 and flu (caused by influenza virus) share the common disease progression asymptomatic (no symptoms), mild symptoms fever or chills,…

ByAnish DesaiSeptember 15, 20200Comments

VIEWPOINTS

PharmaShots Interview: Genentech’s Ted Omachi Shares Insights on Xolair (omalizumab) PFS

The US FDA has accepted the sBLA for a new self-administration option for Xolair (omalizumab) across all approved US indications. In an interview with PharmaShots, Ted Omachi the Global Development Leader for Xolair and Senior Medical Director of Product Development Immunology shares details and highlights of Xolair (omalizumab) PFS for self-administration. Shots: A decision on…

BySenior EditorSeptember 7, 20200Comments

Digital Healthcare in India – Current Trends & Future

Insights+ Key Biosimilars Events of September 2020

Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

COVID-19 – Where Does The Pharmaceutical Industry Go From Here?

Top 20 Oncology Companies by Total Products of 2019

PharmaShots Interview: Genentech’s Dr. Neil Collinson Shares Insights on Xofluza

Insights+: The US FDA New Drug Approvals in August 2020

COVID-19 Treatment in India and Abroad

PharmaShots Interview: Genentech’s Ted Omachi Shares Insights on Xolair (omalizumab) PFS

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter